A detailed history of Savant Capital, LLC transactions in Haleon PLC stock. As of the latest transaction made, Savant Capital, LLC holds 13,251 shares of HLN stock, worth $128,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,251
Holding current value
$128,534
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$8.32 - $10.7 $110,248 - $141,785
13,251 New
13,251 $140,000
Q3 2023

Nov 06, 2023

BUY
$7.85 - $8.94 $25,355 - $28,876
3,230 Added 27.91%
14,804 $123,000
Q2 2023

Aug 04, 2023

BUY
$8.04 - $9.0 $93,054 - $104,166
11,574 New
11,574 $96,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.